152 related articles for article (PubMed ID: 26888232)
1. Cell cycle aberration in ameloblastoma and adenomatoid odontogenic tumor: As evidenced by the expression of p53 and survivin.
Shaikh Z; Niranjan KC
Indian J Dent Res; 2015; 26(6):565-70. PubMed ID: 26888232
[TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen (PCNA) and p53 protein expression in ameloblastoma and adenomatoid odontogenic tumor.
Barboza CA; Pereira Pinto L; Freitas Rde A; Costa Ade L; Souza LB
Braz Dent J; 2005; 16(1):56-61. PubMed ID: 16113935
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of p53 and PCNA in ameloblastoma and adenomatoid odontogenic tumor.
Salehinejad J; Zare-Mahmoodabadi R; Saghafi S; Jafarian AH; Ghazi N; Rajaei AR; Marouzi P
J Oral Sci; 2011 Jun; 53(2):213-7. PubMed ID: 21712626
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of Survivin and its relationship with cell apoptosis and proliferation in ameloblastomas.
González-González R; Molina-Frechero N; Damian-Matsumura P; Salazar-Rodriguez S; Bologna-Molina R
Dis Markers; 2015; 2015():301781. PubMed ID: 25866434
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis and cell cycle aberrations in epithelial odontogenic lesions: An evidence by the expression of p53, Bcl-2 and Bax.
Tenório JR; Santana T; Queiroz SI; de Oliveira DH; Queiroz LM
Med Oral Patol Oral Cir Bucal; 2018 Mar; 23(2):e120-e125. PubMed ID: 29476674
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor.
Krishna A; Kaveri H; Naveen Kumar RK; Kumaraswamy KL; Shylaja S; Murthy S
J Cancer Res Ther; 2012; 8(2):232-7. PubMed ID: 22842367
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of Ki-67 and p53 protein in ameloblastoma and keratocystic odontogenic tumor.
Gadbail AR; Patil R; Chaudhary M
Acta Odontol Scand; 2012 Dec; 70(6):529-35. PubMed ID: 21780975
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of p53 and murine double minute 2 protein in odontogenic keratocyst versus variants of ameloblastoma.
Singh A; Jain A; Shetty DC; Rathore AS; Juneja S
J Cancer Res Ther; 2020; 16(3):521-529. PubMed ID: 32719261
[TBL] [Abstract][Full Text] [Related]
9. Comparative immunohistochemical study of Bcl-X in ameloblastoma, keratocystic odontogenic tumor and adenomatoid odontogenic tumor.
Shukla P; Prabhu S; Jose M; Sripathi Rao BH
J Oral Maxillofac Pathol; 2017; 21(1):51-57. PubMed ID: 28479687
[TBL] [Abstract][Full Text] [Related]
10. TGF-β1, Smad-2/-3, Smad-1/-5/-8, and Smad-4 signaling factors are expressed in ameloblastomas, adenomatoid odontogenic tumors, and calcifying cystic odontogenic tumors: an immunohistochemical study.
Karathanasi V; Tosios KI; Nikitakis NG; Piperi E; Koutlas I; Trimis G; Sklavounou A
J Oral Pathol Med; 2013 May; 42(5):415-23. PubMed ID: 23157422
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical comparison of the expression of p53 and MDM2 proteins in ameloblastomas and keratocystic odontogenic tumors.
Sharifi-Sistani N; Zartab H; Babakoohi S; Saghravanian N; Jamshidi S; Esmaili H; Mohtasham N; Zamanzadeh M; Abbaszadeh-Bidokhty H
J Craniofac Surg; 2011 Sep; 22(5):1652-6. PubMed ID: 21959406
[TBL] [Abstract][Full Text] [Related]
12. Immunoexpression of MMPs-1, -2, and -9 in ameloblastoma and odontogenic adenomatoid tumor.
Ribeiro BF; Iglesias DP; Nascimento GJ; Galvão HC; Medeiros AM; Freitas RA
Oral Dis; 2009 Oct; 15(7):472-7. PubMed ID: 19522745
[TBL] [Abstract][Full Text] [Related]
13. Comparative Immunohistochemical Analysis of p53 and Alpha-SMA in Ameloblastoma, AOT and OKC.
Adesina OM; Adebiyi KE; Effiom OA; Omoniyi-Esan GO; Owotade FJ; Fatusi OA; Kolude B; Odujoko OO; Ladeji A
West Afr J Med; 2022 Mar; 39(3):248-255. PubMed ID: 35366669
[TBL] [Abstract][Full Text] [Related]
14. Adenomatoid odontogenic tumor (AOT) originating in a unicystic ameloblastoma: a case report.
Jivan V; Altini M; Meer S; Mahomed F
Head Neck Pathol; 2007 Dec; 1(2):146-9. PubMed ID: 20614266
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of WNT5A and MMPs in odontogenic epithelial tumors and cysts.
Guimarães DM; Antunes DM; Saturno JL; Massuda F; Paiva KB; Nunes FD
Acta Histochem; 2015 Oct; 117(8):667-74. PubMed ID: 26558991
[TBL] [Abstract][Full Text] [Related]
16. Expression of cell cycle and apoptosis-related proteins in ameloblastoma and keratocystic odontogenic tumor.
Metgud R; Gupta K
Ann Diagn Pathol; 2013 Dec; 17(6):518-21. PubMed ID: 24090509
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of calretinin in ameloblastoma, adenomatoid odontogenic tumor, and keratocystic odontogenic tumor: a comparative study.
Koneru A; Hallikeri K; Nellithady GS; Krishnapillai R; Prabhu S
Appl Immunohistochem Mol Morphol; 2014; 22(10):762-7. PubMed ID: 25046230
[TBL] [Abstract][Full Text] [Related]
18. Beta-catenin and survivin expression in keratocystic odontogenic tumor (KCOT). A comparative immunohistochemical study in primary, recurrent and nevoid basal cell carcinoma syndrome (NBCCS)-associated lesions.
Leonardi R; Matthews JB; Loreto C; Musumeci G; Campisi G; Lo Muzio L; dos Santos JN; Pastorino L; Bufo P; Pannone G
Histol Histopathol; 2013 Sep; 28(9):1175-84. PubMed ID: 23572266
[TBL] [Abstract][Full Text] [Related]
19. p53 and MDM2 expression in odontogenic cysts and tumours.
Carvalhais J; Aguiar M; Araújo V; Araújo N; Gomez R
Oral Dis; 1999 Jul; 5(3):218-22. PubMed ID: 10483067
[TBL] [Abstract][Full Text] [Related]
20. Expression of anti - Apoptotic survivin in odontogenic keratocyst, adenomatoid odontogenic tumor and ameloblastoma.
Latha HA; Prakash AR; Kanth MR; Reddy AVS; Sreenath G; Vidya KS
J Oral Maxillofac Pathol; 2023; 27(3):601. PubMed ID: 38033952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
